| | Reviews Combination therapy in cholesterol reduction: focus on ezetimibe and statins Liliana Grigore, Giuseppe Danilo Norata, and Alberico L Catapano Vasc Health Risk Manag. 2008 April; 4(2): 267–278. Published online 2008 April. PMCID: PMC2496970 Management of venous thromboembolism in patients with cancer: role of dalteparin Lori-Ann Linkins Vasc Health Risk Manag. 2008 April; 4(2): 279–287. Published online 2008 April. PMCID: PMC2496976 Early detection and management of the high-risk patient with elevated blood pressure Cristina Sierra and Alejandro de la Sierra Vasc Health Risk Manag. 2008 April; 4(2): 289–296. Published online 2008 April. PMCID: PMC2496973 Peroxisome proliferator-activated receptor-γ agonists and diabetes: Current evidence and future perspectives Francesco Chiarelli and Daniele Di Marzio Vasc Health Risk Manag. 2008 April; 4(2): 297–304. Published online 2008 April. PMCID: PMC2496982 New anticoagulant strategies in ST elevation myocardial infarction: Trials and clinical implications Conor J McCann and Ian BA Menown Vasc Health Risk Manag. 2008 April; 4(2): 305–313. Published online 2008 April. PMCID: PMC2496975 Expert review on coronary calcium Matthew J Budoff and Khawar M Gul Vasc Health Risk Manag. 2008 April; 4(2): 315–324. Published online 2008 April. PMCID: PMC2496978 Orlistat in the prevention of diabetes in the obese patient Marcio C Mancini and Alfredo Halpern Vasc Health Risk Manag. 2008 April; 4(2): 325–336. Published online 2008 April. PMCID: PMC2496972 Regadenoson in the detection of coronary artery disease Christiane Buhr, Mario Gössl, Raimund Erbel, and Holger Eggebrecht Vasc Health Risk Manag. 2008 April; 4(2): 337–340. Published online 2008 April. PMCID: PMC2496979 Clinical efficacy and safety of statins in managing cardiovascular risk Navin K Kapur and Kiran Musunuru Vasc Health Risk Manag. 2008 April; 4(2): 341–353. Published online 2008 April. PMCID: PMC2496987 Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk Byron J Hoogwerf, Krupa B Doshi, and Dima Diab Vasc Health Risk Manag. 2008 April; 4(2): 355–362. Published online 2008 April. PMCID: PMC2496974 Vascular risk factors, cognitve decline, and dementia E Duron and Olivier Hanon Vasc Health Risk Manag. 2008 April; 4(2): 363–381. Published online 2008 April. PMCID: PMC2496986 Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin Bo Ahrén Vasc Health Risk Manag. 2008 April; 4(2): 383–394. Published online 2008 April. PMCID: PMC2496991 Opinion Risk factors for vascular dementia: Hypotension as a key point Rita Moretti, Paola Torre, Rodolfo M Antonello, Davide Manganaro, Cristina Vilotti, and Gilberto Pizzolato Vasc Health Risk Manag. 2008 April; 4(2): 395–402. Published online 2008 April. PMCID: PMC2496988 Original Research Preferred drug lists: Potential impact on healthcare economics Kimberly Ovsag, Sabrina Hydery, and Shaker A Mousa Vasc Health Risk Manag. 2008 April; 4(2): 403–413. Published online 2008 April. PMCID: PMC2496984 Japanese study to organize proper lifestyle modifications for metabolic syndrome (J-STOP-MetS): Design and method Masanori Munakata, Hiroki Honma, Mitugu Akasi, Takaharu Araki, Takahiko Kawamura, Masashi Kubota, Tomoko Yokokawa, Akira Maruhashi, Toshihiro Toyonaga, and On behalf of the J-STOP-MetS Study Group Vasc Health Risk Manag. 2008 April; 4(2): 415–420. Published online 2008 April. PMCID: PMC2496971 Kennedy space center cardiovascular disease risk reduction program evaluation Kristine S Calderon, Charles Smallwood, and David A Tipton Vasc Health Risk Manag. 2008 April; 4(2): 421–426. Published online 2008 April. PMCID: PMC2496977 Peroxisome proliferator-activated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: A case-cohort study and meta-analyses Mohammad Hadi Zafarmand, Yvonne T van der Schouw, Diederick E Grobbee, Peter W de Leeuw, and Michiel L Bots Vasc Health Risk Manag. 2008 April; 4(2): 427–436. Published online 2008 April. PMCID: PMC2496990 Time-dependent alterations in serum NO concentration after oral administration of l-arginine, l-NAME, and allopurinol in intestinal ischemia/reperfusion Amalia E Yanni, Eleutherios Margaritis, Nikolaos Liarakos, Alkisti Pantopoulou, Maria Poulakou, Maria Kostakis, Despoina Perrea, and Alkis Kostakis Vasc Health Risk Manag. 2008 April; 4(2): 437–441. Published online 2008 April. PMCID: PMC2496980 Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study Jean-Jacques Mourad, Dulce Lameira, and Pierre-Jean Guillausseau Vasc Health Risk Manag. 2008 April; 4(2): 443–451. Published online 2008 April. PMCID: PMC2496983 Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women? Evelyn O Talbott, Jeanne Zborowski, Judy Rager, and Juley R Stragand Vasc Health Risk Manag. 2008 April; 4(2): 453–462. Published online 2008 April. PMCID: PMC2496969 Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy Guliz Kozdag, Ercument Ciftci, Dilek Ural, Tayfun Sahin, Macit Selekler, Aysen Agacdiken, Ali Demirci, Sezer Komsuoglu, and Baki Komsuoglu Vasc Health Risk Manag. 2008 April; 4(2): 463–469. Published online 2008 April. PMCID: PMC2496989 Effect of ramipril on renal function in patients with intermittent claudication Simon D Hobbs, Martin W Claridge, Antonius BM Wilmink, Donald J Adam, Mark E Thomas, and Andrew W Bradbury Vasc Health Risk Manag. 2008 April; 4(2): 471–475. Published online 2008 April. PMCID: PMC2496985 Case Report A young man with acute dilated cardiomyopathy associated with methylphenidate Tor-Bjarne Nymark, A Hovland, H Bjørnstad, and E W Nielsen Vasc Health Risk Manag. 2008 April; 4(2): 477–479. Published online 2008 April. PMCID: PMC2496981 |